Institutional investors purchased a net $11.3 million shares of GSK during the quarter ended June 2016 and now own 9.05% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 130.3 Thousand shares of GlaxoSmithKline
HILTON CAPITAL MANAGEMENT LLC Bought 26.3 Thousand shares of GlaxoSmithKline
CREATIVE PLANNING, INC. Bought 17.7 Thousand shares of GlaxoSmithKline